ATE272049T1 - Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker - Google Patents

Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker

Info

Publication number
ATE272049T1
ATE272049T1 AT00914643T AT00914643T ATE272049T1 AT E272049 T1 ATE272049 T1 AT E272049T1 AT 00914643 T AT00914643 T AT 00914643T AT 00914643 T AT00914643 T AT 00914643T AT E272049 T1 ATE272049 T1 AT E272049T1
Authority
AT
Austria
Prior art keywords
salicylamide
lanthanide complexes
ligands
luminescence markers
salicylamidyl
Prior art date
Application number
AT00914643T
Other languages
English (en)
Inventor
Kenneth N Raymond
Stephane Petoud
Seth Cohen
Jide Xu
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE272049T1 publication Critical patent/ATE272049T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1007—Non-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18—Metal complexes
    • C09K2211/182—Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00914643T 1999-02-18 2000-02-18 Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker ATE272049T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12060099P 1999-02-18 1999-02-18
US09/507,599 US6406297B1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers
PCT/US2000/004284 WO2000048991A1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers

Publications (1)

Publication Number Publication Date
ATE272049T1 true ATE272049T1 (de) 2004-08-15

Family

ID=26818543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00914643T ATE272049T1 (de) 1999-02-18 2000-02-18 Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker

Country Status (9)

Country Link
US (4) US6406297B1 (de)
EP (1) EP1154991B1 (de)
JP (1) JP4943585B2 (de)
AT (1) ATE272049T1 (de)
AU (1) AU762754B2 (de)
CA (1) CA2371818C (de)
DE (1) DE60012485T2 (de)
DK (1) DK1154991T3 (de)
WO (1) WO2000048991A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US6982431B2 (en) 1998-08-31 2006-01-03 Molecular Devices Corporation Sample analysis systems
US6749811B2 (en) 1998-04-28 2004-06-15 The Johns Hopkins University Molecularly imprinted polymer solution anion sensor
US7320784B1 (en) * 1999-02-17 2008-01-22 Bracco Imaging S.P.A. Immobilized labeling compounds and methods
DE60012485T2 (de) * 1999-02-18 2005-08-18 The Regents Of The University Of California, Oakland Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker
CA2371816C (en) * 1999-02-18 2010-04-27 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
DE19936997B4 (de) * 1999-08-02 2007-06-14 Biolitec Ag Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US7067148B2 (en) * 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
EP1415156B1 (de) 2001-07-10 2009-09-02 The Board Of Trustees Of The Leland Stanford Junior University Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen
US7393656B2 (en) 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US6846915B2 (en) * 2001-08-13 2005-01-25 The Regents Of The University Of California Hydroxypyridonate and hydroxypyrimidinone chelating agents
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030180356A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
US20040161737A1 (en) * 2003-02-14 2004-08-19 Yang Dan-Hui D. Novel luminescent metal chelates and methods for their detection
EP1611254B1 (de) 2003-03-31 2014-09-10 Roche Diagnostics GmbH Zusammensetzungen und verfahren zum nachweis bestimmter flaviviren, einschliesslich mitgliedern der japanese-encephalitis-virus-serogruppe
WO2005001415A2 (en) 2003-05-23 2005-01-06 Epix Pharmaceuticals, Inc. Optically pure and enriched isomers of chelating ligands and contrast agents
EP1629269B1 (de) * 2003-05-27 2010-07-21 Alexander Menzel Verfahren zum nachweis von sprengstoffspuren mittels photolumineszenz
ATE407176T1 (de) 2003-12-30 2008-09-15 Univ California Office Of The Aromatische triamid-lanthanid-komplexe
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
US20070009980A1 (en) * 2004-06-01 2007-01-11 Applera Corporation Continuous fluorogenic analyte assays with dendritic amplification of signal
CN1707244B (zh) * 2004-06-11 2010-04-07 中国科学院大连化学物理研究所 一种二氧化钛纳米铕荧光探针
JP5243684B2 (ja) * 2004-11-04 2013-07-24 ユー・ディー・シー アイルランド リミテッド 有機金属錯体、発光性固体、有機ｅｌ素子及び有機ｅｌディスプレイ
AU2005306411A1 (en) * 2004-11-19 2006-05-26 The Scripps Research Institute Subnanomolar precipitator of thiophilic metals
US20060275217A1 (en) * 2005-05-06 2006-12-07 Caravan Peter D Chemical exchange saturation transfer contrast agents
US20100291689A1 (en) * 2006-03-21 2010-11-18 Board Of Supervisors Of Louisiana State University & Agricultural And Mechanical College Lanthanide Complexes as Fluorescent Indicators for Neutral Sugars and Cancer Diagnosis
US8557601B2 (en) * 2006-07-10 2013-10-15 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
US8173800B2 (en) * 2006-08-15 2012-05-08 The Regents Of The University Of California Luminescent macrocyclic lanthanide complexes
US8507199B2 (en) * 2007-01-25 2013-08-13 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
CN101802182A (zh) 2007-08-21 2010-08-11 诺达利蒂公司 用于诊断、预后和治疗方法的方法
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
WO2010075003A1 (en) * 2008-12-16 2010-07-01 The University Of Akron Lanthanide ion complexes and imaging method
US20100233733A1 (en) * 2009-02-10 2010-09-16 Nodality, Inc., A Delaware Corporation Multiple mechanisms for modulation of the pi3 kinase pathway
WO2011025790A1 (en) 2009-08-24 2011-03-03 Lumiphore, Inc. Macrocyclic hopo chelators
US9459246B2 (en) 2009-09-08 2016-10-04 Nodality, Inc. Induced intercellular communication
JP2013515744A (ja) * 2009-12-24 2013-05-09 ルミフォア，インコーポレイテッド 放射性医薬品錯体
US20130078148A1 (en) 2010-06-07 2013-03-28 Konica Minolta Holdings, Inc. Near field-enhanced fluorescence sensor chip
EP2607888B1 (de) 2010-08-17 2022-01-12 Konica Minolta Holdings, Inc. Spfs-sensor mit einem reinigungsmechanismus für unspezifische adsorptionen
JP6043288B2 (ja) 2010-09-15 2016-12-14 エンダセア， インコーポレイテッド 時間分解蛍光ベースのアッセイによるリポ多糖の測定のための使用方法およびキット
DE102011001368B4 (de) * 2011-03-17 2013-01-31 Bundesanstalt für Materialforschung und -Prüfung (BAM) Lanthanoid-Chelate enthaltende Partikel, deren Herstellung sowie deren Verwendung in der Bioanalytik
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
US20140170772A1 (en) 2011-07-28 2014-06-19 Konica Minolta Inc Method for Measuring Amount of Analyte and Device for SPFS
WO2013026790A1 (en) * 2011-08-19 2013-02-28 Dhr Finland Oy Luminescent lanthanide chelates having three chromophores and their use
US9944657B2 (en) 2011-08-19 2018-04-17 Radiometer Turku Oy Luminescent lanthanide chelates having three chromophores an their use
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
CN104125997B (zh) 2011-12-22 2017-03-08 雷度米特图尔库公司 具有提升的激发性质的新型发光镧系元素螯合物
EP2607884A1 (de) * 2011-12-23 2013-06-26 Essilor International (Compagnie Générale d'Optique) Brillenglasbewertung hinsichtlich des Schutzes gegen UV-Gefahren
WO2013124544A1 (fr) 2012-02-22 2013-08-29 Cisbio Bioassays Procede de normalisation de la luminescence emise par un milieu de mesure.
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
WO2013187971A2 (en) 2012-05-31 2013-12-19 The Regents Of The University Of California Macrocycles
AU2013344514B2 (en) 2012-11-16 2017-09-14 Lumiphore, Inc. Di-Macrocycles
WO2014147288A1 (en) 2013-01-31 2014-09-25 Kaivogen Oy Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
US9388110B2 (en) * 2013-12-12 2016-07-12 Saudi Arabian Oil Company Liquid phase oxidation of aromatic feedstocks with manganate recycling to produce carboxylic acids
DE102014203266B4 (de) 2014-02-24 2018-07-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Zusammensetzung mit FRET-Paar in definierter Geometrie
US11691997B2 (en) 2014-04-09 2023-07-04 Lumiphore, Inc. Macrocycles
US10434186B2 (en) 2014-12-22 2019-10-08 Lumiphore, Inc. Functionalized linear ligands and complexes thereof
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
US11248269B2 (en) 2015-03-05 2022-02-15 University Of New Hampshire Methods and compositions for identifying pathogenic vibrio parahaemolyticus
JP7523883B2 (ja) 2015-08-13 2024-07-29 ザ ジェネラル ホスピタル コーポレイション 分子ｍｒイメージング用マンガン系キレートコンジュゲート
CN106010502B (zh) * 2015-11-24 2019-03-01 河北科技大学 一种具有氟离子传感性能的稀土介孔杂化发光材料的制备方法
US11614445B2 (en) 2016-06-09 2023-03-28 Radiometer Turku Oy Background blockers for binding assays
CN106317096B (zh) * 2016-08-19 2019-05-28 华南师范大学 一种邻菲罗啉并咪唑型稀土配位分子基探针及其制备方法和应用
CA3035526A1 (en) 2016-09-02 2018-03-08 Lumiphore, Inc. Macrocyclic ligands with pendant chelating moieties and complexes thereof
WO2018130988A1 (en) 2017-01-12 2018-07-19 Nestec S.A. Cryptate derivatives and their use as luminescent lanthanide complexes
EP3631011B1 (de) * 2017-05-31 2021-06-23 Roche Diagnostics GmbH Multiplex-pcr-detektion von alk-, ret- und ros-fusionen
FR3069644B1 (fr) 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
ES2948008T3 (es) 2017-10-02 2023-08-25 Otsuka Pharma Co Ltd Método para detectar analito
ES2956109T3 (es) 2018-02-15 2023-12-13 Procisedx Inc Analizador
JP2021514052A (ja) 2018-02-15 2021-06-03 プロサイズディーエックス インコーポレーテッド アッセイキュベット
CA3093247A1 (en) 2018-03-07 2019-09-12 Lumiphore, Inc. Macrocyclic ligands with pendant chelating moieties and complexes thereof
ES2859775T3 (es) 2018-07-05 2021-10-04 Univ Strasbourg Nanopartículas de lantánido luminiscentes ultrabrillantes que comprenden terbio, con una mayor vida útil de estado excitado
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
US12352765B2 (en) 2018-11-15 2025-07-08 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of prognosis and classification for preeclampsia
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
WO2020232262A1 (en) 2019-05-16 2020-11-19 Procisedx Inc. Assay detection methods for vcam-1 and calprotectin
JP2022532385A (ja) 2019-05-16 2022-07-14 プロサイセデクス インコーポレイティド 血中のＶＣＡＭ－１及びα２－マクログロブリンの検出のためのアッセイ方法
JP2022534227A (ja) 2019-05-23 2022-07-28 プロサイセデクス インコーポレイティド ヒト血清アルブミン、ビタミンｄ、ｃ反応性タンパク質、及び抗トランスグルタミナーゼ自己抗体の検出のためのアッセイ方法
US20230021481A1 (en) 2019-12-06 2023-01-26 Otsuka Pharmaceutical Co., Ltd. Standard substance for psa quantification, preparation method therefor, standard solution for psa quantification, and psa quantification method
WO2021119583A2 (en) * 2019-12-13 2021-06-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lanthanide compounds for luminescence "turn-on" detection
WO2021242725A1 (en) 2020-05-28 2021-12-02 Procisedx Inc. Predetermined calibration curve
US20230296622A1 (en) 2020-08-17 2023-09-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of predicting time to onset of labor
EP4343775A1 (de) 2022-09-22 2024-03-27 SurgeCare Verfahren zur bestimmung eines medizinischen ergebnisses für eine person, zugehöriges elektronisches system und computerprogramm
WO2025193301A2 (en) * 2023-12-18 2025-09-18 Board Of Regents, The University Of Texas System Supercharged fluorescent biosensors for analyte detection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588265B3 (fr) * 1985-10-04 1988-01-15 Inst Francais Du Petrole Procede d'adoucissement d'une charge d'hydrocarbures contenant des produits soufres
SE8703682L (sv) * 1987-09-24 1989-03-25 Wallac Oy Homogen bestaemningsmetod som utnyttjar affinitetsreaktioner
WO1992011039A1 (en) 1990-12-17 1992-07-09 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Derivatized tris-catechol chelating agents
DE4222255A1 (de) 1992-07-07 1994-01-13 Bayer Ag Fotochemische Markierung von Nukleinsäuren mit Europiumchelat-Reagenzien und ihre Verwendung in Gensondentestsystemen
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE19728021A1 (de) * 1997-07-01 1999-01-07 Clariant Gmbh Metall-Komplexe als Bleichaktivatoren
CA2371816C (en) * 1999-02-18 2010-04-27 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
DE60012485T2 (de) * 1999-02-18 2005-08-18 The Regents Of The University Of California, Oakland Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker

Also Published As

Publication number Publication date
CA2371818A1 (en) 2000-08-24
US7018850B2 (en) 2006-03-28
US20060286567A1 (en) 2006-12-21
US7404912B2 (en) 2008-07-29
JP4943585B2 (ja) 2012-05-30
US20080293155A1 (en) 2008-11-27
DE60012485D1 (de) 2004-09-02
US6406297B1 (en) 2002-06-18
JP2003535812A (ja) 2003-12-02
WO2000048991A1 (en) 2000-08-24
US20030027189A1 (en) 2003-02-06
AU3600600A (en) 2000-09-04
AU762754B2 (en) 2003-07-03
CA2371818C (en) 2009-01-06
DK1154991T3 (da) 2004-11-22
EP1154991A1 (de) 2001-11-21
DE60012485T2 (de) 2005-08-18
EP1154991B1 (de) 2004-07-28

Similar Documents

Publication Publication Date Title
ATE272049T1 (de) Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker
ATE285394T1 (de) Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
EP1706452A4 (de) Aromatische triamid-lanthanid-komplexe
DE69807558D1 (de) Chelatkomplexe paramagnetischer Metalle mit niedriger Toxizität
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
ATE388157T1 (de) Neue phosphitverbindungen und deren rh-komplexe
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
DE60014038D1 (de) Elektrolumineszenzmaterialen
DE60123933D1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
DE60110558D1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
DE69822162D1 (de) Neue tetrazolderivate
DE60014267D1 (de) Magnet aus seltenen erdmetallen für mri abtaster hergestellt aus aufbereitetem, pr-nd enthaltendem erzresiduum
DK1218385T3 (da) Carbonmonoxidkilde til fremstilling af overgangsmetalcarbonylkomplekser
ATE309254T1 (de) Gewebespezifische fluoreszierende chelate
SI1377574T1 (de)
PT920413E (pt) Reagentes complexantes e complexos com compostos boronicos
ATE229819T1 (de) Pseudopolyrotaxane
ATE271395T1 (de) Konjugate von gallensäure derivaten und metallionenchelatkomplexen und ihre verwendung zur beurteilung der microvaskulären permeabilität
YU36104A (sh) Kristalna struktura fosfodiesteraza 5 i njihova upotreba
ATE225330T1 (de) Komplexbildner für boronverbindung und hochstabile komplexe
DE60003560D1 (de) 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate
DE60313331D1 (de) Neue benzonaphthyridine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1154991

Country of ref document: EP